OngoingPhase 2MS (type not specified)2007-005362-12

What it found

Still running

No result yet.

What was tested

Treatment tested

  • ZK 132 281

What it measured

Main measures

  • Primary outcomes:

Who could take part

MS (type not specified)

Inclusion: Inclusion criteria: Exclusion: Exclusion criteria:

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Comparaison et quantification des lésions de SEP prenant le contraste avec l’USPIO (SH U 555 C) ou gadolinium en IRM dans les formes progressives et actives de la SEP.

Loading reviews and guidelines…

History

    1. Started

      Feb 2008

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error